Skip to main content
Log in

Role of Jak Kinases and STATs in Cytokine Signal Transduction

  • Published:
International Journal of Hematology Aims and scope Submit manuscript

Abstract

The Janus family tyrosine kinase—signal transducer and activator of transcription (Jak-STAT) signaling pathway is broadly used by interferons and type I cytokines. These cytokines and interferons activate Janus family tyrosine kinases (Jak kinases), which in turn phosphorylate and thereby activate STAT proteins. Before activation, STAT proteins are cytosolic proteins; after ssactivation, however, they are translocated to the nucleus where they function as transcription factors. This review summarizes salient features of the Jak-STAT pathway and focuses on the functional role of the different Jak kinases and STATs in vivo.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price includes VAT (Canada)

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Darnell JE Jr. STATs and gene regulation.Science. 1997;277:1630–1635.

    Article  CAS  PubMed  Google Scholar 

  2. Leonard WJ, O’Shea JJ. Jaks and STATs: biological implications.Annu Rev Immunol. 1998;16:293–322.

    Article  CAS  PubMed  Google Scholar 

  3. Leonard WJ. Type I cytokines and interferons and their receptors. In: Paul WE, ed.Fundamental Immunology. 4th ed. Philadelphia, PA: Lippincott Raven; 1999:741–774.

    Google Scholar 

  4. Witthuhn BA, Quelle FW, Silvennoinen O, et al. JAK2 associates with the erythropoietin receptor and is tyrosine phosphorylated and activated following stimulation with erythropoietin.Cell. 1993;74:227–236.

    Article  CAS  PubMed  Google Scholar 

  5. Argetsinger LS, Campbell GS, Yang X, et al. Identification of JAK2 as a growth hormone receptor-associated tyrosine kinase.Cell. 1993;74:237–244.

    Article  CAS  PubMed  Google Scholar 

  6. Please see multiple reviews of STAT proteins by multiple authors.Oncogene. 2000;19:2466–2656.

    Article  CAS  PubMed  Google Scholar 

  7. Bhattacharya S, Eckner R, Grossman S, et al. Cooperation of Stat2 and p300/CBP in signalling induced by interferon α.Nature. 1996;383:344–347.

    Article  CAS  PubMed  Google Scholar 

  8. Zhang JJ, Vinkemeier U, Gu W, Chakravarti D, Horvath CM, Darnell JE Jr. Two contact regions between Stat1 and CBP/p300 in interferon gamma signaling.Proc Natl Acad Sci U S A. 1996;93:15092–15096.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Deckeer T, Kovarik P. Serine phosphorylation of STATs.Oncogene. 2000;19:2628–2637.

    Article  CAS  Google Scholar 

  10. Horvath CM, Darnell JE Jr. The state of the STATs: recent developments in the study of signal transduction to the nucleus.Curr Opin Cell Biol. 1997;9:233–239.

    Article  CAS  PubMed  Google Scholar 

  11. Lew DJ, Decker T, Strehlow I, Darnell JE Jr. Overlapping elements in the guanylate-binding protein gene promoter mediate transcriptional induction by alpha and gamma interferons.Mol Cell Biol. 1991;11:182–191.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Xu X, Sun Y-L, Hoey T. Cooperative DNA binding and sequenceselective recognition conferred by the STAT amino terminal domain.Science. 1996;273:794–797.

    Article  CAS  PubMed  Google Scholar 

  13. Vinkemeier U, Cohen SL, Moarefi I, Chait BT, Kuriyan J, Darnell JE Jr. DNA binding of in vitro activated Stat1a, Stat1b and truncated Stat1: interaction between NH2-terminal domains stabilizes binding of two dimers to tandem DNA sites.EMBO J. 1996;15:5616–5626.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  14. Vinkemeier U, Moarefi I, Darnell JE Jr, Kuriyan J. Structure of the amino-terminal protein interaction domain of STAT-4.Science. 1998;279:1048–1052.

    Article  CAS  PubMed  Google Scholar 

  15. John S, Vinkemeier U, Soldaini E, Darnell JE Jr, Leonard WJ. The significance of tetramerization in promoter recruitment by Stat5.Mol Cell Biol. 1999;19:1910–1918.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Soldaini E, John S, Moro S, Bollenbacher J, Schindler U, Leonard WJ. DNA binding site selection of dimeric and tetrameric Stat5 proteins reveals a large repertoire of divergent tetrameric Stat5a binding sites.Mol Cell Biol. 2000;20:389–401.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Kim TK, Maniatis T. Regulation of interferon-gamma-activated STAT1 by the ubiquitin-proteasome pathway.Science. 1996;273:1717–1719.

    Article  CAS  PubMed  Google Scholar 

  18. Subtil A, Rocca A, Dautry-Varsat A. Molecular characterization of the signal responsible for the targeting of the interleukin 2 receptor beta chain toward intracellular degradation.J Biol Chem. 1998;273:29424–29429.

    Article  CAS  PubMed  Google Scholar 

  19. Yasukawa H, Sasaki A, Yoshimura A. Negative regulation of cytokine signaling pathways.Annu Rev Immunol. 2000;18:143–164.

    Article  CAS  PubMed  Google Scholar 

  20. Kovanen PE, Leonard WJ. Cytokine signaling: inhibitors keep cytokines in check.Curr Biol. 1999;9:R899-R902.

    Article  CAS  PubMed  Google Scholar 

  21. Shuai K. Modulation of STAT signaling by STAT-interacting proteins.Oncogene. 2000;19:2638–2644.

    Article  CAS  PubMed  Google Scholar 

  22. Rodig S, Meraz MA, White JM, et al. Disruption of the Jak1 gene demonstrates obligatory and nonreduntant roles of the Jaks in cytokine-induced biologic responses.Cell. 1998;93:373–383.

    Article  CAS  PubMed  Google Scholar 

  23. Parganas E, Wang D, Stravopodis D, et al. Jak2 is essential for signaling through a variety of cytokine receptors.Cell. 1998;93:385–395.

    Article  CAS  PubMed  Google Scholar 

  24. Neubauer H, Cumano A, Müller M, Wu H, Huffstadt U, Pfeffer K. Jak2 deficiency defines an essential developmental checkpoint in definitive hematopoiesis.Cell. 1998;93:397–409.

    Article  CAS  PubMed  Google Scholar 

  25. Noguchi M, Yi H, Rosenblatt HM, et al. Interleukin-2 receptor γ chain mutation results in X-linked severe combined immunodeficiency in humans.Cell. 1993;73:147–157.

    Article  CAS  PubMed  Google Scholar 

  26. Macchi P, Villa A, Gillani S, et al. Mutations of Jak-3 gene in patients with autosomal severe combined immune deficiency (SCID).Nature. 1995;377:65–68.

    Article  CAS  PubMed  Google Scholar 

  27. Russell SM, Tayebi N, Nakajima H, et al. Mutation of Jak3 in a patient with SCID: Essential role of Jak3 in lymphoid development.Science. 1995;270:797–800.

    Article  CAS  PubMed  Google Scholar 

  28. Puel A, Ziegler SF, Buckley RH, Leonard WJ. Defective IL7R expression in T-B+NK+ severe combined immunodeficiency.Nat Genetics. 1998;20:394–397.

    Article  CAS  PubMed  Google Scholar 

  29. Shimoda K, Kato K, Aoki K, et al. Tyk2 plays a restricted role in IFNα signaling, although it is required for IL-12-mediated T cell function.Immunity. 2000;113:561–571.

    Article  Google Scholar 

  30. Karaghiosoff M, Neubauer H, Lassnig C, et al. Partial impairment of cytokine responses in Tyk2-deficient mice.Immunity. 2000;13:549–560.

    Article  CAS  PubMed  Google Scholar 

  31. Meraz MA, White JM, Sheehan KC, et al. Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway.Cell. 1996;84:431–442.

    Article  CAS  PubMed  Google Scholar 

  32. Durbin JE, Hackenmiller R, Simon MC, Levy DE. Targeted disruption of the mouse Stat1 gene results in compromised innate immunity to viral disease.Cell. 1996;84:443–450.

    Article  CAS  PubMed  Google Scholar 

  33. Park C, Li S, Cha E, Schindler C. Immune response in Stat2 knockout mice.Immunity. 2000;13:795–804.

    Article  CAS  PubMed  Google Scholar 

  34. Akira S. Roles of STAT3 define by tissue-specific gene targeting.Oncogene. 2000;19:2607–2611.

    Article  CAS  PubMed  Google Scholar 

  35. Kaplan MH, Sun YL, Hoey T, Grusby MJ. Impaired IL-12 responses and enhanced development of Th2 cells in Stat4- deficient mice.Nature. 1996;382:174–177.

    Article  CAS  PubMed  Google Scholar 

  36. Thierfelder WE, van Deursen JM, Yamamoto K, et al. Requirement for Stat4 in interleukin-12-mediated responses of natural killer and T cells.Nature. 1996;382:171–174.

    Article  CAS  PubMed  Google Scholar 

  37. Lin J-X, Mietz, J, Modi WS, John S, Leonard WJ. Cloning of human Stat5B. Reconstitution of interleukin-2-induced Stat5A and Stat5B DNA binding activity in COS-7 cells.J Biol. Chem. 1996;271:10738–10744.

    Article  CAS  PubMed  Google Scholar 

  38. Liu X, Robinson GW, Gouilleux F, Groner B, Hennighausen L. Cloning and expression of Stat5 and an additional homologue (Stat5b) involved in prolactin signal transduction in mouse mammary tissue.Proc Natl Acad Sci U S A. 1995;92:8831–8835.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  39. Udy GB, Towers RP, Snell RG, et al. Requirement of STAT5b for sexual dimorphism of body growth rates and liver gene expression.Proc Natl Acad Sci U S A. 1997;94:7239–7244.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. Nakajima H, Liu XW, Wynshaw-Boris A, et al. An indirect effect of Stat5a in IL-2-induced proliferation: a critical role for Stat5a in IL-2-mediated IL-2 receptor α chain induction.Immunity. 1997;7:691–701.

    Article  CAS  PubMed  Google Scholar 

  41. Imada K, Bloom ET, Nakajima H, et al. Stat5b is essential for natural killer cell-mediated proliferation and cytolytic activity.J Exp Med. 1998;188:2067–2074.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  42. Moriggl R, Topham DJ, Teglund S, et al. Stat5 is required for IL-2-induced cell cycle progression of peripheral T cells.Immunity. 1999;10:249–259.

    Article  CAS  PubMed  Google Scholar 

  43. Kagami S-I, Nakajima H, Kumano K, et al. Both Stat5a and Stat5b are required for antigen-induced eosinophil and T-cell recruitment into the tissue.Blood. 1999;95:1370–1377.

    Google Scholar 

  44. Kaplan MH, Schindler U, Smiley ST, Grusby MJ. Stat6 is required for mediating responses to IL-4 and for development of Th2 cells.Immunity. 1996;4:313–319.

    Article  CAS  PubMed  Google Scholar 

  45. Shimoda K, van Deursen J, Sangster MY, et al. Lack of IL-4-induced Th2 response and IgE class switching in mice with disrupted Stat6 gene.Nature. 1996;380:630–633.

    Article  CAS  PubMed  Google Scholar 

  46. Migone T-S, Lin J-X, Cereseto A, et al. Constitutively activated Jak- STAT pathway in T cells transformed with HTLV-I.Science 1995;269:79–81.

    Article  CAS  PubMed  Google Scholar 

  47. Takemoto S, Mulloy JC, Cereseto A, et al. Proliferation of adult T cell leukemia/lymphoma cells is associated with the constitutive activation of JAK/STAT proteins.Proc Natl Acad Sci U S A. 1997;94:13897–13902.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  48. Weber-Nordt RM, Egen C, Wehinger J, et al. Constitutive activation of STAT proteins in primary lymphoid and myeloid leukemia cells and in Epstein-Barr virus (EBV)-related lymphoma cell lines.Blood. 1996;88:809–816.

    PubMed  CAS  Google Scholar 

  49. Danial NN, Pernis A, Rothman PB. Jak-STAT signaling induced by the v-abl oncogene.Science. 1995;269:1875–1877.

    Article  CAS  PubMed  Google Scholar 

  50. Yu CL, Meyer DJ, Campbell GS, et al. Enhanced DNA-binding activity of a Stat3-related protein in cells transformed by the Src oncoprotein.Science. 1995;269:81–83.

    Article  CAS  PubMed  Google Scholar 

  51. Bowman T, Garcia R, Turkson J, Jove R. STATs in oncogenesis.Oncogene. 2000;19:2474–2488.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

About this article

Cite this article

Leonard, W.J. Role of Jak Kinases and STATs in Cytokine Signal Transduction. Int J Hematol 73, 271–277 (2001). https://doi.org/10.1007/BF02981951

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02981951

Key words

Navigation